Literature DB >> 2946716

The effects of hyperinsulinemia on serum testosterone, progesterone, dehydroepiandrosterone sulfate, and cortisol levels in normal women and in a woman with hyperandrogenism, insulin resistance, and acanthosis nigricans.

J E Nestler, J N Clore, J F Strauss, W G Blackard.   

Abstract

Insulin may mediate the hyperandrogenism that frequently occurs in patients with insulin-resistant states. To test this hypothesis, we studied five normal women and one woman with hyperandrogenism, insulin resistance, and acanthosis nigricans with the hyperinsulinemic-euglycemic clamp technique. Each woman received a 0.1 U/kg insulin bolus dose, followed by a 10 mU/kg X min insulin infusion for 12-16 h. In the normal women, an average insulin level of 1832 +/- 292 (+/- SEM) microU/ml was achieved; serum glucose was clamped at 116 +/- 5 mg/dl. At this level, insulin may bind to the insulin-like growth factor I receptor as well as to its own receptor. Contrary to our working hypothesis, a rise in serum testosterone did not occur in any women during insulin infusion, and in one women, serum testosterone levels decreased. When analyzed as a percentage of the basal value, serum progesterone levels fell 20% in the normal women within the first 2 h of insulin infusion, but did not change thereafter. Dehydroepiandrosterone sulfate (DHEA-S) levels, however, uniformly and progressively decreased by 39% after 12 h of insulin infusion in the normal women and by 31% at 14 h in the woman with hyperandrogenism, insulin resistance, and acanthosis nigricans. The fall in serum DHEA-S levels was not due to diurnal rhythmicity, as the changes in serum DHEA-S levels did not correlated with those in serum cortisol. Suppression of PRL release also was excluded as a cause of the fall in DHEA-S levels. These results indicate that acute hyperinsulinemia of 12- to 16-h duration does not increase serum testosterone or DHEA-S concentrations and, indeed, can cause a decline in serum DHEA-S levels in both normal women and the single woman studied with hyperandrogenism, insulin resistance, and acanthosis nigricans.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2946716     DOI: 10.1210/jcem-64-1-180

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  20 in total

1.  Dehydroepiandrosterone sulfate levels in women. Relationships with age, body mass index and insulin levels.

Authors:  E Mazza; M Maccario; J Ramunni; C Gauna; A Bertagna; A M Barberis; S Patroncini; M Messina; E Ghigo
Journal:  J Endocrinol Invest       Date:  1999-10       Impact factor: 4.256

2.  Androgen responses to adrenocorticotropic hormone infusion among individual women with polycystic ovary syndrome.

Authors:  Kevin H Maas; Sandy Chuan; Evan Harrison; Heidi Cook-Andersen; Antoni J Duleba; R Jeffrey Chang
Journal:  Fertil Steril       Date:  2016-07-26       Impact factor: 7.329

Review 3.  Dehydroepiandrosterone and diseases of aging.

Authors:  R R Watson; A Huls; M Araghinikuam; S Chung
Journal:  Drugs Aging       Date:  1996-10       Impact factor: 3.923

4.  Three-month treatment with metformin or dexfenfluramine does not modify the effects of diet on anthropometric and endocrine-metabolic parameters in abdominal obesity.

Authors:  S E Oleandri; M Maccario; R Rossetto; M Procopio; S Grottoli; E Avogadri; C Gauna; C Ganzaroli; E Ghigo
Journal:  J Endocrinol Invest       Date:  1999-02       Impact factor: 4.256

Review 5.  Disordered follicle development.

Authors:  R Jeffrey Chang; Heidi Cook-Andersen
Journal:  Mol Cell Endocrinol       Date:  2012-07-31       Impact factor: 4.102

6.  Susceptibility to db gene and streptozotocin-induced diabetes in C57BL mice: control by gender-associated, MHC-unlinked traits.

Authors:  E H Leiter; P H Le; D L Coleman
Journal:  Immunogenetics       Date:  1987       Impact factor: 2.846

7.  Bone mineral density in hyperandrogenic amenorrhoea.

Authors:  J Prezelj; A Kocijancic
Journal:  Calcif Tissue Int       Date:  1993-06       Impact factor: 4.333

8.  Effect of insulin and testosterone on androgen production and transcription of SULT2A1 in the NCI-H295R adrenocortical cell line.

Authors:  Ashim Kumar; Denis Magoffin; Iqbal Munir; Ricardo Azziz
Journal:  Fertil Steril       Date:  2008-08-05       Impact factor: 7.329

9.  Sex-specific action of insulin to acutely increase the metabolic clearance rate of dehydroepiandrosterone in humans.

Authors:  J E Nestler; Z Kahwash
Journal:  J Clin Invest       Date:  1994-10       Impact factor: 14.808

10.  Evidence for insulin suppression of baseline luteinizing hormone in women with polycystic ovarian syndrome and normal women.

Authors:  Mark A Lawson; Sonia Jain; Shelly Sun; Ketan Patel; Pamela J Malcolm; R Jeffrey Chang
Journal:  J Clin Endocrinol Metab       Date:  2008-03-11       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.